Provided by: Chunghwa Chemical Synthesis & Biotech Co.,Ltd
SEQ_NO
3
Date of announcement
2022/03/08
Time of announcement
20:43:52
Subject
The Board of Directors Resolved to Distribute Dividend.
Date of events
2022/03/08
To which item it meets
paragraph 14
Statement
1.Date of the board of directors resolution :2022/03/08
2.Year or quarter which dividends belong to:Year 2021
3.Period which dividends belong to:2021/01/01~2021/12/31
4.Appropriations of earnings in cash dividends to shareholders
(NT$ per share):1.3
5.Cash distributed from legal reserve and capital surplus to shareholders
(NT$ per share):0
6.Total amount of cash distributed to shareholders (NT$):100,828,000
7.Appropriations of earnings in stock dividends to shareholders
(NT$ per share):0
8.Stock distributed from legal reserve and capital surplus to shareholders
(NT$ per share):0
9.Total amount of stock distributed to shareholders (shares):0
10.Any other matters that need to be specified:None
11.Per value of common stock:NT$10
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chunghwa Chemical Synthesis & Biotech Co. Ltd. published this content on 08 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 March 2022 13:02:04 UTC.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.